Second malignant tumours in childhood Hodgkin's disease

Medical and Pediatric Oncology

Volumn 26, Issue 6, 1996, Pages 373-379

  Jenkin, Derek ^a   Greenberg, Mark ^a   Fitzgerald, Annette ^a  

^a Toronto Sunnybrook 1994 Reg C ^*

Author keywords

childhood; Hodgkin's disease; second malignant tumours

Indexed keywords

ANTINEOPLASTIC AGENT; METHOTREXATE; PREDNISONE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SECOND CANCER;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CLINICAL PROTOCOLS; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INCIDENCE; LAPAROTOMY; MALE; MECHLORETHAMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; ONTARIO; PREDNISONE; PROCARBAZINE; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RISK FACTORS; SPLENECTOMY; VINCRISTINE;

EID: 0029925061     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199606)26:6<373::AID-MPO1>3.0.CO;2-E     Document Type: Article

References (21)

1. Henry-Amar M: Second cancer after the treatment of Hodgkin's disease: A report from the international database on Hodgkin's disease. Ann Oncol 3:S117-S128, 1992.
2. Kaldor JM, Day NE, Band P, Choi NW, Clarke EA, Coleman MP, Hakama M, Koch M, Langmark F, Neal FE, Pettersson F, Pompe-Kirn V, Prior P, Storm HH: Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries. Int J Cancer 39:571-585, 1987.
3. Blayney DW, Longo DL, Young RC, Greene MH, Hubbard SM, Postal MG, Duffey PL, DeVita VT: Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's. N Engl J Med 316:710-714, 1987.
4. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA: Risk of second cancers after treatment for Hodgkin's disease. N Eng J Med 318:76-81, 1988.
5. Cimino G, Papa G, Tura S, Mazza P, Rossi Femni PL, Bosi A, Amadori S, Lo Coco F, D'Arcangelo E, Giannarelli D, Mandelli F: Second primary cancer following Hodgkin's disease: Updated results of an Italian multi-centre study. J Clin Oncol 9:432-437, 1991.
6. Urba WJ, Longo DL: Hodgkin's disease. N Engl J Med 326:678-687, 1992.
7. Tucker MA, Meadows AT, Boice JD, Hoover RN, Fraumeni JF: Cancer risk following treatment of childhood cancer. In Boice JD, Fraumeni JR (eds): "Radiation Carcinogenesis: Epidemiology and Biological Significance." New York: Raven Press, 1984, pp. 211-224.
8. Hawkins MM, Draper GJ, Kingston JE: Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 56:339-347, 1987.
9. de Vathaire F, Schweisguth O, Rodary C, François P, Sarrazin D, Oberlin O, Hill C, Raquin MA, Dutreix A, Flamant R: Long-term risk of second malignant neoplasm after cancer in childhood. Br J Cancer 59:448-452, 1989.
10. Green DM, Zevon MA, Reese PA, Cowrie GS, Gaeta JF, Pearce JI, Michalek AM, Stevens EA: Second malignant tumors following treatment during childhood and adolescence for cancer. Med Pediatr Oncol 22:1-10, 1994.
11. Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RDT, Marsden B, Nesbit M, Newton W, Oberlin O, Sallan SG, Siegel S, Strong LC, Voûte PA: Second malignant neoplasms in children: An update from the Late Effects Study Group. J Clin Oncol 3:532-538, 1985.
12. Meadows AT, Obringer AC, Marrero O, Oberlin O, Robison L, Fossati-Bellani F, Green D, Voûte PA, Morris-Jones P, Greenberg M, Baum E, Ruymann F: Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Pediatr Oncol 17:477-484, 1989.
13. Jenkin D, Doyle J, Berry M, Blanchette V, Chan H, Doherty M, Freedman M, Greenberg M, Panzarella T, Saunders F, Sonley M, Weizmann S, Zipursky A: Hodgkin's disease in children: Treatment with MOPP and low dose, extended field irradiation without laparotomy. Late results and toxicity. Med Pediatr Oncol 18:265-272, 1990.
14. Jenkin D, Freedman M, McClure P, Peters V, Saunders F, Sonley M: Hodgkin's disease in children: Treatment with low dose radiation and MOPP without staging laparotomy. Cancer 44:80-86, 1979.
15. Kaldor JM, Day NE, Clarke A, van Leeuwen FE, Henry-Amar M, Florentino MV, Bell J, Pederson D, Bard P, Assouline D, Koch M, Choi W, Prior P, Blair V, Langmark F, Pompe Kirn V, Neal F, Peters D, Pfeiffer R, Karjaleinen S, Cuzick J, Sutcliffe SB, Somers R, Pellae-Cosset B, Pappagallo GL, Fraser P, Storm H, Stovall M: Leukemia following Hodgkin's disease. N Engl J Med 322:7-13, 1990.
16. Pedersen-Bjeregaard J, Specht L, Bleson Larsen S, Ersboll J, Struck J, Hansen MM, Hansen HH, Nissen NI: Risk of therapyrelated leukaemia and preleukaemia after Hodgkin's disease. Lancet 6:83-88, 1987.
17. Pui C-H, Hancock ML, Raimondi SC, Head DR, Thompson E, Wilimas J, Kun LE, Bowman LC, Crist WM, Pratt CB: Myeloid ncoplasia in children treated for solid tumours. Lancet 336:417-421, 1990.
18. Van Leeuwen FE, Somers R, Hart AAM: Splenectomy in Hodgkin's disease and second leukaemias [letter]. Lancet 2:210-211, 1987.
19. Van der Velden JW, Van Putten WLJ, Guinee VF, Pfeiffer R, Van Leeuwen FE, Van der Linden EAM, Vardomskaya I, Lane W, Durand M, Lagarde C, Hagemeister FB, Hagenbeek A, Eghbali H: Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease. Int J Cancer 42:252-255, 1988.
20. Tucker MA, Meadows AT, Boice JD, Stovall M, Oberlin O, Stone BJ, Birch J, Voûte PA, Hoover RN, Fraumeni JF: Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 78:459-464, 1987.
21. Tucker MA, Morris-Jones PH, Boice JD, Robison LL, Stone BJ, Stovall M, Jenkin RDT, Lubin JH, Baum ES, Siegel SE, Meadows AT, Hoover RN, Fraumeni JF: Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 51:2885-2888, 1991.